phytic acid has been researched along with oxidopamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandy, B; Davison, AJ | 1 |
Bandy, B; Davison, AJ; Moon, J; Walter, PB | 1 |
Hou, L; Ju, C; Li, X; Liu, C; Lv, Y; Wang, X; Wang, Y; Zhang, J; Zhang, Z | 1 |
3 other study(ies) available for phytic acid and oxidopamine
Article | Year |
---|---|
Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: mechanisms by which metal chelation enhances inhibition by superoxide dismutase.
Topics: Adenosine Diphosphate; Catalase; Chelating Agents; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Hydroxydopamines; Ligands; Metals; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Superoxide Dismutase | 1987 |
Reaction of oxygen with 6-hydroxydopamine catalyzed by Cu, Fe, Mn, and V complexes: identification of a thermodynamic window for effective metal catalysis.
Topics: Adenosine Diphosphate; Bromides; Buffers; Catalysis; Copper; Deferoxamine; Edetic Acid; Histidine; Hydrogen-Ion Concentration; Iron; Ligands; Manganese; Osmolar Concentration; Oxidation-Reduction; Oxidopamine; Oxygen; Phytic Acid; Sodium Compounds; Thermodynamics; Vanadium | 2001 |
Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and α-synuclein aggregation in 6-OHDA induced parkinson's disease cell model.
Topics: Adrenergic Agents; alpha-Synuclein; Apoptosis; Blotting, Western; Cell Line, Tumor; Flow Cytometry; Humans; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phytic Acid | 2016 |